Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
15.62
-0.02 (-0.13%)
At close: Feb 11, 2026, 4:00 PM EST
15.85
+0.23 (1.46%)
After-hours: Feb 11, 2026, 4:20 PM EST
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of $2.4 billion as of February 11, 2026. Its market cap has increased by 107.34% in one year.
Market Cap
2.40B
Enterprise Value
2.36B
1-Year Change
107.34%
Ranking
Category
Stock Price
$15.62
Market Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.77B to $2.40B, a decrease of -49.69%. That is a compound annual growth rate of -9.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 2.40B | -3.12% |
| Dec 31, 2025 | 2.48B | 180.23% |
| Dec 31, 2024 | 884.74M | 24.72% |
| Dec 29, 2023 | 709.39M | -35.07% |
| Dec 30, 2022 | 1.09B | -72.41% |
| Dec 31, 2021 | 3.96B | -51.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beam Therapeutics | 2.69B |
| Travere Therapeutics | 2.69B |
| Spyre Therapeutics | 2.64B |
| Arcus Biosciences | 2.61B |
| Mineralys Therapeutics | 2.51B |
| Wave Life Sciences | 2.50B |
| Telix Pharmaceuticals | 2.37B |
| Ultragenyx Pharmaceutical | 2.30B |